Granato, M
~ 900  Ergebnisse:
Personensuche X
?
1

51P Phase IB (Ph1b), MESOVAX clinical trial of pembrolizuma..:

Ridolfi, L. ; Delmonte, A. ; De Rosa, F....
Immuno-Oncology and Technology.  20 (2023)  - p. 100524 , 2023
 
?
2

49P Exploiting multi-omic integrated data from DC-vaccinate..:

Bulgarelli, J. ; Tazzari, M. ; Carloni, S....
Immuno-Oncology and Technology.  16 (2022)  - p. 100154 , 2022
 
?
3

48P Phase II trial on vaccination with autologous dendritic..:

Ridolfi, L. ; Gurrieri, L. ; Riva, M.N....
Immuno-Oncology and Technology.  16 (2022)  - p. 100153 , 2022
 
?
4

CNS Hypomyelination Disrupts Axonal Conduction and Behavior..:

Madden, M. E. ; Suminaite, D. ; Ortiz, E....
The Journal of Neuroscience.  41 (2021)  44 - p. 9099-9111 , 2021
 
?
5

Citrus biotechnology: What has been done to improve disease..:

Caserta, R. ; Teixeira-Silva, N.S. ; Granato, L.M....
Biotechnology Research and Innovation.  3 (2019)  - p. 95-109 , 2019
 
?
 
?
 
?
12

The neurogenetic frontier--lessons from misbehaving zebrafi..:

Burgess, H. A. ; Granato, M.
Briefings in Functional Genomics and Proteomics.  7 (2008)  6 - p. 474-482 , 2008
 
1-15